Zephyrus was acquired by BioTechne in March 2016.
Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Addressing the burgeoning single-cell analysis market, our first product, the Z1TM System, enables western blotting on individual cells for the first time. Researchers utilize Zephyrus’s products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development.
Zephyrus spun out from Dr. Amy Herr’s laboratory at U.C. Berkeley in 2013 and is affiliated with QB3, CLSI/BayBio, StartX Med, a Stanford-affiliated nonprofit technology accelerator, and SkyDeck, the premier accelerator at U.C. Berkeley. Zephyrus is also a graduate of Steve Blank’s Lean Launchpad for Life Sciences and Healthcare.